(Q45477179)

14 December 2017

Induction of human papilloma virus E6/E7-specific cytotoxic T-lymphocyte activity in immune-tolerant, E6/E7-transgenic mice (English)

1 reference

14 December 2017

0 references

0 references

human papilloma virus

object named as

human papilloma virus

1 reference

5

Wilschut J

1 reference

14 December 2017

Riezebos-Brilman A

1

1 reference

14 December 2017

Regts J

2

1 reference

14 December 2017

Freyschmidt EJ

3

1 reference

14 December 2017

Dontje B

4

1 reference

14 December 2017

Daemen T

6

1 reference

14 December 2017

1 September 2005

1 reference

14 December 2017

1 reference

14 December 2017

12

1 reference

14 December 2017

18

1 reference

14 December 2017

1410-1414

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302536

14 December 2017

0 references

cites work

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Human papillomavirus immortalization and transformation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

E7-specific cytotoxic T cell tolerance in HPV-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Immune evasion in human papillomavirus-associated cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

The Semliki Forest virus vector induces p53-independent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

inferred from DOI database lookup

7 January 2021

based on heuristic

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302536

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302536

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference